Influence of Krebs-cycle intermediates on survival in hemorrhagic shock.
D000136:Acid-Base Equilibrium; D000818:Animals; D001639:Bicarbonates / Q000097:blood; D002952:Citric Acid Cycle; D005260:Female; D005650:Fumarates / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D006982:Hypertonic Solutions; D007275:Injections, Intravenous; D007656:Ketoglutaric Acids / Q000494:pharmacology*; D008722:Methods; D010071:Oxaloacetates / Q000494:pharmacology*; D011817:Rabbits; D012771:Shock, Hemorrhagic / Q000401:mortality*; D012965:Sodium Chloride / Q000494:pharmacology
D001639:Bicarbonates; D005650:Fumarates; D006982:Hypertonic Solutions; D007656:Ketoglutaric Acids; D010071:Oxaloacetates; D012965:Sodium Chloride; D005947:Glucose